Author(s):
Sushil D. Patil, Shaikh Abdul Muqeet, Sanjay J. Kshirsagar
Email(s):
sushilpharma@rediffmail.com
DOI:
10.5958/0974-4150.2018.00145.1 
Address:
Sushil D. Patil*, Shaikh Abdul Muqeet*, Dr. Sanjay J. Kshirsagar
MET’s Institute of Pharmacy, MET League of Colleges, Bhujbal Knowledge City, Adgaon, Nashik, Maharashtra State 422003, India.
*Corresponding Author
Published In:
Volume - 11,
Issue - 5,
Year - 2018
ABSTRACT:
Canagliflozin, being a Sodium Glucose co-Transporter type 2 (SGLT2) Inhibitor, as a new class for treatment of Type 2 diabetes mellitus, offer a novel mechanism of action, which has been recently approved by USFDA for use in type 2 diabetes mellitus, either alone or in combination with other oral hypoglycemic agents and insulin. The aim of this review firstly to focus on a comprehensive update of chromatography determination of Canagliflozin in bulk and in pharmaceutical preparations, In which has been described using TLC, HPLC/MS, RP-HPLC and UV methods. Secondly to localize the chromatographic conditions for separation and quantification. This review provides detailed information on separation conditions for Canagliflozin alone, with Metformin and in the presence of its degradation product.
Cite this article:
Sushil D. Patil, Shaikh Abdul Muqeet, Sanjay J. Kshirsagar. Review Study on Canagliflozin. Asian J. Research Chem. 2018; 11(5):819-823. doi: 10.5958/0974-4150.2018.00145.1
Cite(Electronic):
Sushil D. Patil, Shaikh Abdul Muqeet, Sanjay J. Kshirsagar. Review Study on Canagliflozin. Asian J. Research Chem. 2018; 11(5):819-823. doi: 10.5958/0974-4150.2018.00145.1 Available on: https://ajrconline.org/AbstractView.aspx?PID=2018-11-5-10